Related Experiment Video

Updated: Mar 15, 2026

Assessment of Vascular Regeneration in the CNS Using the Mouse Retina
07:32

Assessment of Vascular Regeneration in the CNS Using the Mouse Retina

Published on: June 23, 2014

14.9K

Retinal regeneration mechanisms linked to multiple cancer molecules: A therapeutic conundrum

Amanda Barber1, Kyle Farmer2, Keith R Martin3

  • 1John van Geest Centre for Brain Repair, University of Cambridge, UK.

Progress in Retinal and Eye Research
|September 3, 2016
PubMed

Insights

Researchers are exploring cancer genes to repair damaged vision. Modulating these genes shows promise for retinal ganglion cell regeneration, offering new therapeutic avenues for visual system repair despite clinical challenges.

Area of Science:

  • Ophthalmology
  • Oncology
  • Neuroscience

Background:

  • Retinal ganglion cells (RGCs) are crucial for vision and their damage leads to irreversible blindness.
  • Recent research has identified genetic and molecular targets that promote RGC regeneration and neuroprotection.
  • Many identified targets are genes frequently mutated in various cancers.

Purpose of the Study:

  • To review the potential of modulating cancer genes for therapeutic repair of the visual system.
  • To explore the clinical challenges associated with using cancer gene modulation for vision restoration.
  • To discuss signaling mechanisms in cancer that could enhance optic nerve axonal regeneration.

Main Methods:

  • Literature review of recent research on RGC regeneration and neuroprotection.
  • Analysis of genetic and molecular targets implicated in both cancer and visual system repair.
  • Discussion of cancer-related signaling pathways and their potential application to optic nerve regeneration.

Main Results:

  • Several genetic and molecular targets promoting RGC repair are also implicated in cancer development.
  • Modulating these shared targets presents a potential therapeutic strategy for visual system damage.
  • Cancer-related signaling pathways offer insights into mechanisms for improving axonal regeneration.

Conclusions:

  • Targeting cancer genes represents a novel therapeutic strategy for visual system repair.
  • Clinical implementation requires careful consideration of potential challenges and safety profiles.
  • Understanding cancer signaling pathways may unlock new approaches for optic nerve regeneration and vision recovery.
Keywords:
Axon regenerationCancer genesPTENRetinal ganglion cellsVisual system repair mechanisms

More Related Videos

Reconstruct Human Retinoblastoma In Vitro06:52

Reconstruct Human Retinoblastoma In Vitro

Published on: October 11, 2022

1.8K
Author Spotlight: Exploring Retinal Regeneration Mechanisms in the Xenopus Frog09:29

Author Spotlight: Exploring Retinal Regeneration Mechanisms in the Xenopus Frog

Published on: October 13, 2023

2.4K

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.9K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

2.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.3K